Patent ID: 11970499
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The compound of claim 1, wherein the compound is selected from the group consisting of:
N-(3-chlorophenyl)-2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (1);
2-(pyridin-4-yl)-N-(m-tolyl)pyrazolo[1,5-c]pyrimidin-3-amine (2);
2-(pyridin-4-yl)-N-(3-(trifluoromethyl)phenyl)pyrazolo[1,5-c]pyrimidin-3-amine (3);
N,N-dimethyl-3-((2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)amino)benzamide (4);
N-(3-isopropylphenyl)-2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (5);
N1,N1-dimethyl-N3-(2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)benzene-1,3-diamine (6);
N-(3-((2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)amino)phenyl)acetamide (7);
N-(pyridin-2-yl)-2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (8);
N-(3-chlorobenzyl)-2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (9);
N-(pyridin-3-ylmethyl)-2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (10);
N1,N1-dimethyl-N3-(2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)propane-1,3-diamine (11);
3-chloro-N-(2-(pyridin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)benzamide (12);
N-(3-chlorophenyl)-2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (13);
2-(pyrimidin-4-yl)-N-(3-(trifluoromethyl)phenyl)pyrazolo[1,5-c]pyrimidin-3-amine (14);
N-(3-isopropylphenyl)-2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (15);
N1,N1-dimethyl-N3-(2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)benzene-1,3-diamine (16);
N-(3-((2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)amino)phenyl)acetamide (17);
N,N-dimethyl-3-((2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)amino)benzamide (18);
N-(3-chlorobenzyl)-2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-amine (19);
3-chloro-N-(2-(pyrimidin-4-yl)pyrazolo[1,5-c]pyrimidin-3-yl)benzamide (20);
and a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof.